Life Science Compliance Update

As cross-border business and technology advances, the European Union’s need to address data privacy protection continually rises.…

Patient assistance programs have been in the spotlight for the past few years as the drug pricing controversy comes to a head.…

Achieving patient adherence to prescribed medication through clinical educator programs is not a new concept. Neither is the U.S.…

As we noted in last month’s issue, the FDA issued a slew of last-minute Obama Administration guidances. Overlooked among all the…

On December 7, 2016, the HHS Office of the Inspector General ("OIG") approved new safe harbors to the federal anti-kickback…

Life sciences compliance departments are under constant pressure to roll out updated and comprehensive training that addresses a…

The purpose of this article is to give manufacturers some initial background on the topics and some tools that could be…

Although the new code of conduct for member medical device and in-vitro diagnostic companies operating in the European marketplace…

Over the last several years, the pharmaceutical industry has seen a steady increase in state legislation targeting the cost of…

On January 9, 2017, a physician was sentenced for his role in a criminal health care fraud scheme totaling approximately $2.8…